Our systematic review is the first meta-analysis that quantified the association between diabetic status and tumor characteristics, namely tumor size, grade, ER, PR, and Her2 status in women diagnosed with breast cancer, on the basis of epidemiological studies. The gene discussed is ESR1; the disease is breast carcinoma.